Pablo Manuel Lamelas
Latest contributions
First guidelines for the treatment of LM disease issued by SOLACI and SIAC
22 May 2025 – From EuroPCR 2025
During EuroPCR 2025, Cleverson Zukowski and Pablo Lamelas introduce a landmark initiative: the first clinical guidelines for left main disease specifically developed for Latin America.
Published by the Latin American Society of Interventional Cardiology (SOLACI) and the Interamerican Society of Cardiology (SIAC), these recommendations aim to support...
Large retroperitoneal bleed despite state-of-the-art femoral access
01 Nov 2018
There is conventional knowledge stating that retroperitoneal bleeding, a potentially life-threatening complication of femoral access, is a consequence of a high puncture. We highlight a case in which arterial access was not high based on multiple image modalities, single arterial puncture and still developed severe retroperitoneal...
Author
